Foot Locker Stock a...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$3.11 -0.01 | -0.32%
06/19/13 - 10:07 AM ET
28.89K / 265.80K
Vol / Avg. Vol:3.11 / 3.12
Open / Prev. Close:3.09 - 3.12
Today's Range:2.91 - 8.18
52 Wk Range:-47.85%
Performance YTD:TheStreet Rating:
Portfolios with CYCC
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
Latest CYCC Headlines from TheStreet
- 5 Stocks Insiders Love Right Now 05.29.13 | 12:05 pm
- Cyclacel Pharmaceuticals Announces Closing Of Underwritten Offering 05.21.13 | 04:05 pm
- Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering 05.16.13 | 09:05 am
- Cyclacel Pharmaceuticals Announces Proposed Public Offering Of Common Stock 05.15.13 | 04:05 pm
- Cyclacel Reports First Quarter 2013 Financial Results 05.13.13 | 04:05 pm
- Cyclacel Pharmaceuticals To Announce Release Of First Quarter 2013 Financial Results 05.10.13 | 07:05 am
- Cyclacel Reports Updated Phase 2 Survival Data Of Sapacitabine For MDS 04.30.13 | 07:04 am
- Cyclacel Pharmaceuticals To Present At The 12th Annual Needham Healthcare Conference 04.23.13 | 07:04 am
- Reminder: Cyclacel Pharmaceuticals' 6% Preferred Stock Goes Ex-Dividend Soon 04.16.13 | 01:04 pm
- Combination Potential Of Cyclacel's Sapacitabine And Seliciclib Reported At AACR 04.09.13 | 02:04 pm
Press Releases for CYCC
Partner Headlines for CYCC
- Cyclacel Pharma to Offer New Sapacitabine Data at ASH on Dec. 9th - Benzinga 12.04.12 | 09:12 am
- Upcoming AML Treatments - Which Company Will Fly? - Seeking Alpha 12.03.12 | 09:12 am
- 4 Cash Loaded Biotech Stocks With Little Debt - Seeking Alpha 08.30.12 | 09:08 am
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
